Update: 50 percent of patients in Cedars-Sinai brain cancer study alive after 5 years

Eight of 16 patients participating in a study of an experimental immune system therapy directed against the most aggressive malignant brain tumors — glioblastoma multiforme — survived longer than five years after diagnosis, according to Cedars-Sinai researchers, who presented findings Nov. 23 at the Fourth Quadrennial Meeting of the World Federation of Neuro-Oncology.

Fuente : http://www.eurekalert.org/pub_releases/2013-11/cmc…